Technology Enabled Strategies to Promote Treatment Adherence in Liver Transplant
NCT05260268
Summary
Liver transplantation is increasingly performed for older adults with multiple comorbidities. Medication adherence is key to maintaining proper function of the transplanted liver and optimize health; however, adhering to post-transplant treatment is complex. This trial will study how available technology combined with transplant center resources and caregiver support can optimize medication adherence, quality of life, and health outcomes among new liver transplant recipients at 3 centers.
Eligibility
Liver Transplant Recipient Inclusion Criteria: * 18 years or older * Within 3 months of liver transplant * English or Spanish-speaking * Home-dwelling\* * Patient or care partner owns a smart phone and is comfortable receiving text messages and/or using the internet on the smart phone. * \*The definition of "home" includes hotel or short-term housing. Patients who are going to a rehabilitation or skilled nursing facility (SNF) immediately after transplant may still be recruited if the site-PI/Co-I determines they are likely to be discharged to home within 3 months post-transplant. Care Partner Inclusion Criteria: * 18 years or older * English or Spanish speaking * Care partner has access to a smart phone and is comfortable receiving text messages and/or using the internet on the smart phone. Liver Transplant Recipient Exclusion Criteria: * Liver transplant recipient who speaks neither English nor Spanish * Any severe uncorrectable vision, hearing, or cognitive impairments that may impede study interviews Care Partner Exclusion Criteria: * Care partner who speaks neither English nor Spanish
Conditions5
Locations3 sites
Florida
1 siteIllinois
1 sitePennsylvania
1 siteBrowse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
NCT05260268